BRICKELL BIOTECH INC(NASDAQ:BBI) stock News

BBI Latest News, Press Relases and Analysis

All

Press Releases

2 years ago - By: Fresh Tracks Therapeutics, Inc. - Mentions: FRTX

Fresh Tracks Therapeutics Announces Second Adjournment of Special Meeting of Stockholders

2 years ago - By: Fresh Tracks Therapeutics, Inc. - Mentions: FRTX

Fresh Tracks Therapeutics Announces Adjournment of Special Meeting of Stockholders

2 years ago - By: Fresh Tracks Therapeutics, Inc. - Mentions: FRTX

Fresh Tracks Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update

2 years ago - By: Fresh Tracks Therapeutics, Inc. - Mentions: FRTX

Fresh Tracks Therapeutics Announces Board Approval of Plan of Liquidation and Dissolution

2 years ago - By: Fresh Tracks Therapeutics, Inc. - Mentions: FRTX

Fresh Tracks Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update

3 years ago - By: Brickell Biotech

Brickell Biotech Announces 1-For-45 Reverse Stock Split

3 years ago - By: Benzinga

Recap: Brickell Biotech Q1 Earnings

2 years ago - By: Fresh Tracks Therapeutics, Inc. - Mentions: FRTX

Fresh Tracks Announces $8.25 Million Buyout of Its Right to Receive Future Sofpironium Bromide Payments from Botanix

2 years ago - By: Fresh Tracks Therapeutics, Inc. - Mentions: FRTX

Fresh Tracks Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update

3 years ago - By: Fresh Tracks Therapeutics, Inc. - Mentions: FRTX

Fresh Tracks Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

3 years ago - By: Fresh Tracks Therapeutics, Inc. - Mentions: FRTX

Fresh Tracks Therapeutics Announces Positive Topline Results from Single and Multiple Ascending Dose Parts of Phase 1 Study of Oral DYRK1A Inhibitor FRTX-02

3 years ago - By: Fresh Tracks Therapeutics, Inc. - Mentions: FRTX

Fresh Tracks Therapeutics Appoints Andrew Sklawer as Chief Executive Officer

3 years ago - By: Fresh Tracks Therapeutics, Inc. - Mentions: FRTX

Fresh Tracks Therapeutics to Report Third Quarter 2022 Financial Results and Provide a Corporate Update on November 10, 2022

3 years ago - By: Benzinga

Brickell Biotech's Return On Capital Employed Insights

3 years ago - By: Brickell Biotech, Inc.

Brickell Biotech Reports Second Quarter 2022 Financial Results and Provides Corporate Update

3 years ago - By: Brickell Biotech

Brickell Biotech to Participate at William Blair Biotech Focus Conference 2022

3 years ago - By: InvestorPlace - Mentions: XCUR REVB MARK SCWO ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

3 years ago - By: InvestorPlace

Brickell Biotech (BBI) Stock Gains 50% Ahead of Meeting to Prevent Delisting

3 years ago - By: Brickell Biotech

Brickell Biotech Reports First Quarter 2022 Financial Results and Provides Corporate Update

3 years ago - By: Brickell Biotech

BRICKELL BIOTECH INC (BBI) Stock News

BBI Latest News, Press Relases and Analysis

Fresh Tracks Therapeutics Announces Second Adjournment of Special Meeting of Stockholders

Fresh Tracks Therapeutics Announces Adjournment of Special Meeting of Stockholders

Fresh Tracks Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Fresh Tracks Therapeutics Announces Board Approval of Plan of Liquidation and Dissolution

Fresh Tracks Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update

Brickell Biotech Announces 1-For-45 Reverse Stock Split

Recap: Brickell Biotech Q1 Earnings

Fresh Tracks Announces $8.25 Million Buyout of Its Right to Receive Future Sofpironium Bromide Payments from Botanix

Fresh Tracks Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update

Fresh Tracks Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

Fresh Tracks Therapeutics Announces Positive Topline Results from Single and Multiple Ascending Dose Parts of Phase 1 Study of Oral DYRK1A Inhibitor FRTX-02

Fresh Tracks Therapeutics Appoints Andrew Sklawer as Chief Executive Officer

Fresh Tracks Therapeutics to Report Third Quarter 2022 Financial Results and Provide a Corporate Update on November 10, 2022

Brickell Biotech's Return On Capital Employed Insights

Brickell Biotech Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Brickell Biotech to Participate at William Blair Biotech Focus Conference 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Brickell Biotech (BBI) Stock Gains 50% Ahead of Meeting to Prevent Delisting

Brickell Biotech Reports First Quarter 2022 Financial Results and Provides Corporate Update

Brickell Biotech to Report First Quarter 2022 Financial Results and Provide a Corporate Update on May 12, 2022